Why the study?
What is the incidence and prognostic impact of venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer?
Population
384 patients receiving perioperative chemotherapy for potentially curative intent for esophagogastric cancer…
Design
Cohort
Authors
Loading...
VTE incidence warrants surveillance in perioperative esophagogastric chemotherapy; leaves open whether prophylaxis improves outcomes in observational data.
What is the incidence and prognostic impact of venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer?
Venous thromboembolism is a frequent complication (12.5%) in patients receiving perioperative chemotherapy for esophagogastric cancer, but it does not appear to worsen overall prognosis or survival.
Khanna et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: